No Data
No Data
It's Down 26% But Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Could Be Riskier Than It Looks
The Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) share price has fared very poorly over the last month, falling by a substantial 26%. Instead of being rewarded, shareholders who hav
ST Bering (002424.SZ): Accumulated cost of 84.62 million yuan to buy back 0.83% of shares
Glonghui, May 7 | ST Bering (002424.SZ) announced that as of April 30, 2024, the total number of shares repurchased by the company through centralized bidding transactions through the stock repurchase special securities account was 11,668,812 shares, accounting for 0.83% of the company's current total share capital. The highest transaction price was 8.22 yuan/share, the minimum transaction price was 6.59 yuan/share, and the total transaction amount was 84,620,058.20 yuan (excluding transaction fees).
Guizhou Bailing (002424.SZ) announced first-quarter results, net profit of 51.6951 million yuan, a decrease of 44.00%
According to the Zhitong Finance App, Guizhou Bailing (002424.SZ) released its report for the first quarter of 2024. The company's revenue was 1,333 billion yuan, an increase of 22.09% over the previous year. Net profit attributable to shareholders of listed companies was RMB 51.6951 million, a year-on-year decrease of 44.00%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 44.6057 million yuan, a year-on-year decrease of 49.57%. Basic earnings per share were $0.04.
Guizhou Bailing (002424.SZ) was approved as the first grade 2 protected variety of traditional Chinese medicine
Guizhou Bailing (002424.SZ) announced, recently, the China Drug Administration (“State Drug Administration”)...
Guizhou Bailing (002424.SZ) has repurchased a total of 0.83% of its shares at a cost of about 84.62 million yuan
Guizhou Bailing (002424.SZ) issued an announcement. As of March 31, 2024, the company has approved share repurchases...
Painful Week for Retail Investors Invested in Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) After 5.5% Drop, Institutions Also Suffered Losses
Key Insights Guizhou Bailing Group Pharmaceutical's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 21 investo
No Data